The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NSKBT     2-[[(2R)-3-acetyloxy-2- hydroxy-propoxy]...

Synonyms: LMGP01050043, PC(2:0/0:0), 1-acetyl-sn-glycero-3-phosphocholine
This record was replaced with 5311265.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of LMGP01050043


Psychiatry related information on LMGP01050043


High impact information on LMGP01050043


Chemical compound and disease context of LMGP01050043


Biological context of LMGP01050043


Anatomical context of LMGP01050043


Associations of LMGP01050043 with other chemical compounds


Gene context of LMGP01050043


Analytical, diagnostic and therapeutic context of LMGP01050043


  1. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Yan, J.J., Jung, J.S., Lee, J.E., Lee, J., Huh, S.O., Kim, H.S., Jung, K.C., Cho, J.Y., Nam, J.S., Suh, H.W., Kim, Y.H., Song, D.K. Nat. Med. (2004) [Pubmed]
  2. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Kabarowski, J.H., Zhu, K., Le, L.Q., Witte, O.N., Xu, Y. Science (2001) [Pubmed]
  3. Ischemia induces partial loss of surface membrane polarity and accumulation of putative calcium ionophores. Molitoris, B.A., Wilson, P.D., Schrier, R.W., Simon, F.R. J. Clin. Invest. (1985) [Pubmed]
  4. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. Zembowicz, A., Jones, S.L., Wu, K.K. J. Clin. Invest. (1995) [Pubmed]
  5. Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats. Lee, E.S., Soliman, K.F., Charlton, C.G. Neurotoxicology (2005) [Pubmed]
  6. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces the change of calcium mobilization via TRPC ion channels in cultured human corporal smooth muscle cells. So, I., Chae, M.R., Kim, S.J., Lee, S.W. Int. J. Impot. Res. (2005) [Pubmed]
  7. Lysophosphatidylcholine-induced lysis of erythrocytes in Duchenne and myotonic dystrophies and in Huntington's disease. Omachi, A., Sarpel, G., Podolski, J.L., Barr, A.N., Lazowski, E., Danon, M.J. J. Neurol. Sci. (1982) [Pubmed]
  8. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Lauber, K., Bohn, E., Kröber, S.M., Xiao, Y.J., Blumenthal, S.G., Lindemann, R.K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., Xu, Y., Autenrieth, I.B., Schulze-Osthoff, K., Belka, C., Stuhler, G., Wesselborg, S. Cell (2003) [Pubmed]
  9. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Volanakis, J.E., Wirtz, K.W. Nature (1979) [Pubmed]
  10. Phospholipid methylation and biological signal transmission. Hirata, F., Axelrod, J. Science (1980) [Pubmed]
  11. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. Aprahamian, T., Rifkin, I., Bonegio, R., Hugel, B., Freyssinet, J.M., Sato, K., Castellot, J.J., Walsh, K. J. Exp. Med. (2004) [Pubmed]
  12. Impaired hepatic handling and processing of lysophosphatidylcholine in rats with liver cirrhosis. Angelico, M., Alvaro, D., Cantafora, A., Masella, R., Gaudio, E., Gandin, C., Ginanni Corradini, S., Ariosto, F., Riggio, O., Capocaccia, L. Gastroenterology (1991) [Pubmed]
  13. Induction of delayed afterdepolarizations and triggered activity in canine Purkinje fibers by lysophosphoglycerides. Pogwizd, S.M., Onufer, J.R., Kramer, J.B., Sobel, B.E., Corr, P.B. Circ. Res. (1986) [Pubmed]
  14. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. Kishi, Y., Okudaira, S., Tanaka, M., Hama, K., Shida, D., Kitayama, J., Yamori, T., Aoki, J., Fujimaki, T., Arai, H. J. Biol. Chem. (2006) [Pubmed]
  15. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. Blondeau, N., Lauritzen, I., Widmann, C., Lazdunski, M., Heurteaux, C. J. Cereb. Blood Flow Metab. (2002) [Pubmed]
  16. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. Kim, S.J., Gershov, D., Ma, X., Brot, N., Elkon, K.B. J. Exp. Med. (2002) [Pubmed]
  17. Influence of lysophosphatidylcholine on the C-apolipoprotein content of rat and human triglyceride-rich lipoproteins during triglyceride hydrolysis. Windler, E.E., Preyer, S., Greten, H. J. Clin. Invest. (1986) [Pubmed]
  18. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. Kume, N., Gimbrone, M.A. J. Clin. Invest. (1994) [Pubmed]
  19. Electrophysiologic effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs. Akita, H., Creer, M.H., Yamada, K.A., Sobel, B.E., Corr, P.B. J. Clin. Invest. (1986) [Pubmed]
  20. Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Palombo, J.D., Lopes, S.M., Zeisel, S.H., Jenkins, R.L., Albers, J.J., Blackburn, G.L., Bistrian, B.R. Gastroenterology (1987) [Pubmed]
  21. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. Murugesan, G., Fox, P.L. J. Clin. Invest. (1996) [Pubmed]
  22. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. McMurray, H.F., Parthasarathy, S., Steinberg, D. J. Clin. Invest. (1993) [Pubmed]
  23. Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes. Liu, E., Goldhaber, J.I., Weiss, J.N. J. Clin. Invest. (1991) [Pubmed]
  24. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Ylä-Herttuala, S., Palinski, W., Rosenfeld, M.E., Parthasarathy, S., Carew, T.E., Butler, S., Witztum, J.L., Steinberg, D. J. Clin. Invest. (1989) [Pubmed]
  25. Lysophosphatidylcholine increases 3-Hydroxy-3-methylglutaryl-coenzyme A reductase gene expression in CaCo-2 cells. Muir, L.V., Born, E., Mathur, S.N., Field, F.J. Gastroenterology (1996) [Pubmed]
  26. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. Bünemann, M., Liliom, K., Brandts, B.K., Pott, L., Tseng, J.L., Desiderio, D.M., Sun, G., Miller, D., Tigyi, G. EMBO J. (1996) [Pubmed]
  27. The Galpha protein controls a pH-dependent signal path to the induction of phytoalexin biosynthesis in Eschscholzia californica. Viehweger, K., Schwartze, W., Schumann, B., Lein, W., Roos, W. Plant Cell (2006) [Pubmed]
  28. Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Pierce, G.N., Kutryk, M.J., Dhalla, N.S. Proc. Natl. Acad. Sci. U.S.A. (1983) [Pubmed]
  29. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. Kume, N., Cybulsky, M.I., Gimbrone, M.A. J. Clin. Invest. (1992) [Pubmed]
  30. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. Ahmed, Z., Ravandi, A., Maguire, G.F., Emili, A., Draganov, D., La Du, B.N., Kuksis, A., Connelly, P.W. J. Biol. Chem. (2001) [Pubmed]
  31. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine. Murakami, N., Yokomizo, T., Okuno, T., Shimizu, T. J. Biol. Chem. (2004) [Pubmed]
  32. Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity. Fang, X., Gibson, S., Flowers, M., Furui, T., Bast, R.C., Mills, G.B. J. Biol. Chem. (1997) [Pubmed]
  33. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines. Kim, J.H., Lee, B.D., Kim, Y., Lee, S.D., Suh, P.G., Ryu, S.H. J. Immunol. (1999) [Pubmed]
  34. Physical principles underlying the transduction of bilayer deformation forces during mechanosensitive channel gating. Perozo, E., Kloda, A., Cortes, D.M., Martinac, B. Nat. Struct. Biol. (2002) [Pubmed]
  35. On the mechanism of lysophosphatidylcholine-induced depolarization of cat ventricular myocardium. Clarkson, C.W., Ten Eick, R.E. Circ. Res. (1983) [Pubmed]
  36. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells. Inoue, N., Hirata, K., Yamada, M., Hamamori, Y., Matsuda, Y., Akita, H., Yokoyama, M. Circ. Res. (1992) [Pubmed]
  37. Prostanoids and leukotrienes in experimental feline cholecystitis. Kaminski, D.L., Daneshmand, H., Dean, P., Deshpande, Y.G. Hepatology (1990) [Pubmed]
WikiGenes - Universities